Zareei F.a· Veidebaum T.b· Harro J.c

Author affiliations

aInstitute of Psychology, University of Tartu, Tartu, Estonia
bDepartment of Chronic Diseases, National Institute for Health Development, Tallinn, Estonia
cChair of Neuropsychopharmacology, Institute of Chemistry, University of Tartu, Tartu, Estonia

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: March 16, 2022
Accepted: June 23, 2022
Published online: August 23, 2022

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Abstract

Introduction: The interaction of environmental and inherited factors determines how a young person becomes involved in problem behaviours such as drinking alcohol. We have investigated whether the association of family relationships with early experience with alcohol is related to variation in the serotonin transporter gene promoter region (5-HTTLPR). Methods: We used data of the two birth cohorts of the Estonian Personality Behaviour and Health Study (original n = 1,238) at age 15 and 18 years. Data were self-reported in a laboratory setting. Results: Family relationships at age 15 years were significantly related to the frequency of drinking alcohol. Specifically, association of Warmth in Family (closeness and support within family) with consuming alcohol was in a negative, while maltreatment (misprize and abuse) in a positive relationship with alcohol consumption. At age 18 years, the effects of family relationships on consuming alcohol were lower and no longer statistically significant (p values >0.10). The associations between family relations and alcohol use at age 15 years varied by the 5-HTTLPR genotype: at this age, the impact of the family relations, both Warmth and Maltreatment, on the frequency of drinking alcohol was statistically significant among participants with the S/L genotype, and while rather similar results were obtained for the S/S genotype, no relations were apparent between family relations and consuming alcohol in subjects with the L/L genotype. Conclusion: These findings reveal that family relations are related to alcohol consumption, dependent upon the 5-HTTLPR genotype. This is compatible with the hypothesis that the S-allele carriers are more malleable by the environment.

© 2022 S. Karger AG, Basel

References Ghin F, Beste C, Stock AK. Neurobiological mechanisms of control in alcohol use disorder: moving towards mechanism-based non-invasive brain stimulation treatments. Neurosci Biobehav Rev. 2022;133:104508. World Health Organization. Global status report on alcohol and health 2018. World Health Organization; 2018. Available from: https://apps.who.int/iris/handle/10665/274603. GBD 2016 Alcohol Collaborators; Fullman N, Hawley C, Arian N, Zimsen SR, Tymeson HD, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018 Sep 22;392(10152):1015–35. Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019 Feb;21(2):10. Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019 Aug 31;394(10200):781–92. Ducci F, Goldman D. Genetic approaches to addiction: genes and alcohol. Addiction. 2008 Sep;103(9):1414–28. Farris SP, Wolen AR, Miles MF. Using expression genetics to study the neurobiology of ethanol and alcoholism. Int Rev Neurobiol. 2010 Jan 1;91:95–128. Costin BN, Miles MF. Molecular and neurologic responses to chronic alcohol use. Handb Clin Neurol. 2014 Jan 1;125:157–71. Bakhireva LN, Garrison L, Shrestha S, Sharkis J, Miranda R, Rogers K. Challenges of diagnosing fetal alcohol spectrum disorders in foster and adopted children. Alcohol. 2018 Mar 1;67:37–43. Edenberg HJ, Foroud T. Genetics and alcoholism. Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):487–94. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996 Jan;66(6):2621–4. Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996 Dec 1;1(6):453–60. Malik A, Saha S, Morya RK, Bhadada SK, Rana SV. Impact of serotonin transporter gene polymorphism on gut motility in patients with type 2 diabetes mellitus. J Neurogastroenterol Motil. 2021Apr 30;27(2):240–7. McHugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW. The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug Alcohol Depend. 2010 Apr 1;108(1–2):1–6. Villalba K, Attonito J, Mendy A, Devieux JG, Gasana J, Dorak TM. A meta-analysis of the associations between the SLC6A4 promoter polymorphism (5HTTLPR) and the risk for alcohol dependence. Psychiatr Genet. 2015 Apr 1;25(2):47–58. Cao J, Hudziak JJ, Li D. Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder. Neuropsychopharmacology. 2013 Aug;38(9):1737–47. Navarro-Mateu F, Quesada MP, Escámez T, Alcaráz MJ, Seiquer de la Peña C, Salmerón D, et al. Childhood adversities and 5-HTTLPR polymorphism as risk factors of substance use disorders: retrospective case-control study in Murcia (Spain). BMJ Open. 2019 Sep 1;9(9):e030328. Hariri AR, Tessitore A, Mattay VS, Fera F, Weinberger DR. The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage. 2002 Sep 1;17(1):317–23. Gonda X, Fountoulakis KN, Harro J, Pompili M, Akiskal HS, Bagdy G, et al. The possible contributory role of the S allele of 5-HTTLPR in the emergence of suicidality. J Psychopharmacol. 2011 Jul;25(7):857–66. Enoch MA. Genetic and environmental influences on the development of alcoholism: resilience vs. risk. Ann N Y Acad Sci. 2006 Dec;1094(1):193–201. Wall TL, Luczak SE, Hiller-Sturmhöfel S. Biology, genetics, and environment: underlying factors influencing alcohol metabolism. Alcohol Res. 2016;38(1):59–68. Moore GF, Cox R, Evans RE, Hallingberg B, Hawkins J, Littlecott HJ, et al. School, peer and family relationships and adolescent substance use, subjective wellbeing, and mental health symptoms in Wales: a cross sectional study. Child Indic Res. 2018 Dec;11(6):1951–65. Trucco EM, Colder CR, Wieczorek WF. Vulnerability to peer influence: a moderated mediation study of early adolescent alcohol use initiation. Addict Behav. 2011 Jul 1;36(7):729–36. Kask K, Markina A, Podana Z. The effect of family factors on intense alcohol use among european adolescents: a multilevel analysis. Psychiatry J. 2013 Mar;2013:250215. Cope LM, Munier EC, Trucco EM, Hardee JE, Burmeister M, Zucker RA, et al. Effects of the serotonin transporter gene, sensitivity of response to alcohol, and parental monitoring on risk for problem alcohol use. Alcohol. 2017 Mar 1;59:7–16. van der Zwaluw CS, Engels RCME, Vermulst AA, Franke B, Buitelaar J, Verkes RJ, et al. Interaction between dopamine D2 receptor genotype and parental rule-setting in adolescent alcohol use: evidence for a gene-parenting interaction. Mol Psychiatry. 2010 Jul;15(7):727–35. Hirschi T. Causes of delinquency. Routledge; 2017 Jul 28. Kochanska G. Children’s temperament, mothers’ discipline, and security of attachment: multiple pathways to emerging internalization. Child Dev. 1995 Jun;66(3):597–615. Baumrind D. Effective parenting during the early adolescent transition. In: Family transitions. Psychology Press; 1991. Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull. 1992 Jul;112(1):64–105. Nilsson KW, Sjöberg RL, Damberg M, Alm PO, Öhrvik J, Leppert J, et al. Role of the serotonin transporter gene and family function in adolescent alcohol consumption. Alcohol Clin Exp Res. 2005 Apr;29(4):564–70. Kaufman J, Yang BZ, Douglas-Palumberi H, Crouse-Artus M, Lipschitz D, Krystal JH, et al. Genetic and environmental predictors of early alcohol use. Biol Psychiatry. 2007 Jun 1;61(11):1228–34. Laucht M, Treutlein J, Schmid B, Blomeyer D, Becker K, Buchmann AF, et al. Impact of psychosocial adversity on alcohol intake in young adults: moderation by the LL genotype of the serotonin transporter polymorphism. Biol Psychiatry. 2009 Jul 15;66(2):102–9. Harro M, Eensoo D, Kiive E, Merenäkk L, Alep J, Oreland L, et al. Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Nov 1;25(8):1497–511. Kiive E, Laas K, Vaht M, Veidebaum T, Harro J. Stressful life events increase aggression and alcohol use in young carriers of the GABRA2 rs279826/rs279858 A-allele. Eur Neuropsychopharmacol. 2017 Aug 1;27(8):816–27. Tomson K, Merenäkk L, Loit HM, Mäestu J, Harro J. The relationship between serotonin transporter gene promoter polymorphism and serum lipid levels at young age in a longitudinal population-representative study. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Dec 1;35(8):1857–62. Paaver M, Kurrikoff T, Nordquist N, Oreland L, Harro J. The effect of 5-HTT gene promoter polymorphism on impulsivity depends on family relations in girls. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1263–8. Urberg K, Goldstein MS, Toro PA. Supportive relationships as a moderator of the effects of parent and peer drinking on adolescent drinking. J Res Adolesc. 2005 Mar;15(1):1–19. Barnes GM, Hoffman JH, Welte JW, Farrell MP, Dintcheff BA. Effects of parental monitoring and peer deviance on substance use and delinquency. J Marriage Fam. 2006 Nov;68(4):1084–104. Su J, Kuo SIC, Aliev F, Guy MC, Derlan CL, Edenberg HJ, et al. Influence of parental alcohol dependence symptoms and parenting on adolescent risky drinking and conduct problems: a family systems perspective. Alcohol Clin Exp Res. 2018 Sep;42(9):1783–94. Smith L, Watson M, Gates S, Ball D, Foxcroft D. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol. 2008 Jan 15;167(2):125–38. Branje S. Development of parent-adolescent relationships: conflict interactions as a mechanism of change. Child Dev Perspect. 2018 Sep;12(3):171–6. Hung CC, Yen LL, Wu WC. Association of parents’ alcohol use and family interaction with the initiation of alcohol use by sixth graders: a preliminary study in Taiwan. BMC Public Health. 2009 Dec;9(1):172–9. White J, Halliwell E. Alcohol and tobacco use during adolescence: the importance of the family mealtime environment. J Health Psychol. 2010 May;15(4):526–32. Fisher LB, Miles IW, Austin SB, Camargo CA, Colditz GA. Predictors of initiation of alcohol use among US adolescents: findings from a prospective cohort study. Arch Pediatr Adolesc Med. 2007 Oct 1;161(10):959–66. Wood MD, Read JP, Mitchell RE, Brand NH. Do parents still matter? Parent and peer influences on alcohol involvement among recent high school graduates. Psychol Addict Behav. 2004 Mar;18(1):19–30. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Hoehe M, et al. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res. 1997 Nov;21(8):1356–9. Kweon YS, Lee HK, Lee CT, Lee KU, Pae CU. Association of the serotonin transporter gene polymorphism with Korean male alcoholics. J Psychiatr Res. 2005 Jul 1;39(4):371–6. Comings DE, MacMurray JP. Molecular heterosis: a review. Mol Genet Metab. 2000 Sep–Oct;71(1–2):19–31. Belsky J. Differential susceptibility to environmental influences. Int J Child Care Educ Policy. 2013 Nov;7(2):15–31. Akkermann K, Kaasik K, Kiive E, Nordquist N, Oreland L, Harro J. The impact of adverse life events and the serotonin transporter gene promoter polymorphism on the development of eating disorder symptoms. J Psychiatr Res. 2012 Jan 1;46:38–43. Harro J, Merenäkk L, Nordquist N, Konstabel K, Comasco E, Oreland L. Personality and the serotonin transporter gene: associations in a longitudinal population-based study. Biol Psychol. 2009 Apr 1;81:9–13. Article / Publication Details

First-Page Preview

Received: March 16, 2022
Accepted: June 23, 2022
Published online: August 23, 2022

Number of Print Pages: 9
Number of Figures: 2
Number of Tables: 3

ISSN: 0302-282X (Print)
eISSN: 1423-0224 (Online)

For additional information: https://www.karger.com/NPS

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.